Also known as: Evista; Keoxifene; LY156758
Raloxifene is a second-generation selective estrogen receptor modulator (SERM) that acts as an estrogen agonist on bone and an antagonist on breast and uterine tissue. It is approved for prevention and treatment of osteoporosis and reduction of invasive breast cancer risk. Mediocon Inc manufactures GMP-compliant Raloxifene at its Aurangabad facility.
| Parameter | Specification |
|---|---|
| CAS Number | 84449-90-1 |
| Molecular Formula | C₂₈H₂₇NO₄S |
| Molecular Weight | 473.58 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Selective Estrogen Receptor Modulator (SERM) |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | RAL/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |